95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
47.14%
Revenue growth above 1.5x OR's 9.92%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
70.16%
Gross profit growth above 1.5x OR's 10.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
78.16%
EBIT growth above 1.5x OR's 15.15%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
78.16%
Operating income growth above 1.5x OR's 7.56%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
96.62%
Net income growth above 1.5x OR's 26.20%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
84.21%
EPS growth above 1.5x OR's 21.43%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
105.88%
Diluted EPS growth above 1.5x OR's 21.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
81.11%
OCF growth above 1.5x OR's 11.49%. David Dodd would confirm a clear edge in underlying cash generation.
-3124.58%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
81.04%
10Y revenue/share CAGR under 50% of OR's 191.83%. Michael Burry would suspect a lasting competitive disadvantage.
36841732.28%
5Y revenue/share CAGR above 1.5x OR's 29.95%. David Dodd would look for consistent product or market expansions fueling outperformance.
59.87%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
1234.52%
5Y OCF/share CAGR above 1.5x OR's 192.29%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
14311.97%
3Y OCF/share CAGR at 50-75% of OR's 22738.42%. Martin Whitman would suspect weaker recent execution or product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
26453.71%
5Y net income/share CAGR above 1.5x OR's 117.59%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
1590.09%
3Y net income/share CAGR above 1.5x OR's 86.14%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
672.20%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
21.16%
AR growth well above OR's 8.62%. Michael Burry fears inflated revenue or higher default risk in the near future.
-28.98%
Inventory is declining while OR stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
117.23%
Asset growth above 1.5x OR's 3.85%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
50.21%
BV/share growth above 1.5x OR's 5.86%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-33.80%
We cut SG&A while OR invests at 19.74%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.